<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE paragraph PUBLIC "-//IFRS//DTD DITA Paragraph//EN" "../../../DocTypes/com.ifrs.doctype/dtd/paragraph.dtd"><paragraph id="IFRS15_B59A"><paranum class="- topic/title paragraph/paranum "/><titlealts><navtitle>B59A</navtitle></titlealts><prolog><data name="standard_number" value="IFRS&#xa0;15"/><data name="paranum" value="B59A"/></prolog><body><variant id="IFRS15_B59A_V1" base="F48807152"> <p id="IFRS15_P0723">An entity&#x2019;s activities significantly affect the intellectual property to which the <xref base="F31716740" href="IFRS15_APPA.dita#IFRS15_APPA/IFRS15_P0502">customer<ph outputclass="def_xref"><xref keyref="GLOSSARY_customer"/></ph></xref> has rights when either: </p> <ol outputclass="static" id="IFRS15_L0080" base="F48807154" type="lower-alpha"><li><li_value>(a)</li_value> <p id="IFRS15_P0724" base="F48807155">those activities are expected to significantly change the form (for example, the design or content) or the functionality (for example, the ability to perform a function or task) of the intellectual property; or</p></li><li><li_value>(b)</li_value> <p id="IFRS15_P0725" base="F48807157">the ability of the customer to obtain benefit from the intellectual property is substantially derived from, or dependent upon, those activities. For example, the benefit from a brand is often derived from, or dependent upon, the entity&#x2019;s ongoing activities that support or maintain the value of the intellectual property.</p></li></ol> <p id="IFRS15_P0726" base="F48807158">Accordingly, if the intellectual property to which the customer has rights has significant stand-alone functionality, a substantial portion of the benefit of that intellectual property is derived from that functionality. Consequently, the ability of the customer to obtain benefit from that intellectual property would not be significantly affected by the entity&#x2019;s activities unless those activities significantly change its form or functionality. Types of intellectual property that often have significant stand-alone functionality include software, biological compounds or drug formulas, and completed media content (for example, films, television shows and music recordings).</p>  </variant></body></paragraph>